FUNDAMENTALS · Fundamentals · US Healthcare

SANUWAVE Health (SNWV) Fundamentals 2026 — P/E 3.4x, Revenue Analysis | SniperIQ

SANUWAVE Health (SNWV) is a US-listed Healthcare company in Medical - Equipment & Services with a market capitalization of $51M, trading at $5.97 on the NASDAQ. This SniperIQ fundamentals page covers SANUWAVE Health's valuation (P/E 3.4x, P/B 27.9x), profitability (net margin 36.2%), revenue ($44M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$51M
P/E (TTM)3.4x
Net Margin36.2%
Revenue (FY25)$44M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is SANUWAVE Health's market cap?

SANUWAVE Health (SNWV) has a market capitalization of approximately $51M, trading at $5.97 on the NASDAQ. Market cap moves with the live share price.

What is SANUWAVE Health's P/E ratio?

SANUWAVE Health's trailing twelve-month P/E ratio is 3.4x, with a price-to-book (P/B) of 27.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is SANUWAVE Health?

SANUWAVE Health runs a net profit margin of 36.2%, a gross margin of 75.7%, and an operating margin of 6.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does SANUWAVE Health generate?

SANUWAVE Health reported revenue of $44M for fiscal year 2025, with net income of

2M and earnings per share (EPS) of 1.38. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does SANUWAVE Health pay a dividend?

SANUWAVE Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is SANUWAVE Health financially healthy?

SANUWAVE Health carries a debt-to-equity ratio of 12.06x and a current ratio of 1.31x, with a market beta of 1.42. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is SANUWAVE Health a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For SANUWAVE Health (SNWV) the key facts are: market cap $51M, P/E 3.4x, revenue $44M, 52-week range 5.96-46.585. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track SANUWAVE Health's full fundamentals live

Get SANUWAVE Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Pulmonx (LUNG) fundamentals · Seres Therapeutics (MCRB) fundamentals · Daxor (DXR) fundamentals · UG Healthcare (8K7) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons